In a study that evaluated the gene expression of this cytokine in NAFLD, there was a marked increase in TGF-β1 gene expression in patients with NASH compared with simple steatosis (P = 0.0002) (49). Here, TGFB1 is linked to metabolic dysfunction-associated steatotic liver disease.